Skip to main content
Clinical Trials/ACTRN12605000373673
ACTRN12605000373673
Completed
Phase 3

A single blind randomised controlled trial comparing the use of Nicotine Replacement Therapy (NRT) while still smoking for 2 weeks prior to quitting followed by usual NRT practice, with usual NRT cessation practice on smoking abstinence at 6 months.

Health Research Council (NZ)0 sites1,100 target enrollmentSeptember 13, 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Smoking
Sponsor
Health Research Council (NZ)
Enrollment
1100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Health Research Council (NZ)

Eligibility Criteria

Inclusion Criteria

  • Participants will be smokers from throughout New Zealand, who are interested in quitting within the next few days or at most within 2 weeks. Participants will be eligible for inclusion in the trial provided that they are eligible for subsidised NRT according to Quitline criteria. These are as follows: at least 18 years of age, have their first cigarette within 30 minutes of waking (a measure of nicotine dependency)have a telephone, and are able to provide consent.

Exclusion Criteria

  • People will be excluded from the trial if they meet any of the criteria used by Quitline and other cessation providers to decline NRT or to seek medical approval. These are as follows:are pregnant or breastfeedingare current users of NRT productsuse non\-cigarette tobacco products (e.g. snuff, pipes, cigars)Is not currently using Zyban (Buproprion) or Nortriptylinehave had a stroke or heart related condition in the last 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised controlled single blind trial comparing STTJ (scapho-trapezio-trapezoid joint)fusion and pyrocarbon interposition arthroplasty for osteoarthritis of the scapho-trapezio-trapezoid jointMusculoskeletal Diseases: Osteoarthritis (OA)Musculoskeletal DiseasesOsteoarthritis (OA)
ISRCTN12076542Record Provided by the NHSTCT Register - 2006 Update - Department of Health80
Completed
Not Applicable
To compare the safety and efficacy of 'low dose' vaginal misoprostol and dinoprostone vaginal gel for induction of labour at term
ISRCTN85744560Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)200
Not yet recruiting
Phase 2
study to compare treatment options in for warts using MMR vaccine and vitamin D injectioHealth Condition 1: B079- Viral wart, unspecified
CTRI/2023/08/056461sushil kumar singh
Completed
Not Applicable
A single-blind randomized controlled trial comparing Aprepitant plus (Granisetron)1st 5-HT3 receptor antagonist and Palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapies including CBDCA in the gynecology cancer patients.Patients with gynecologic cancer receiving chemotherapy including carboplatin (that is, TC therapy: carboplatin + paclitaxel)
JPRN-UMIN000008552St. Mariannna University, School of Medicine300
Recruiting
Not Applicable
Eye Movement Desensitisation and Re-programming (EMDR) therapy for the treatment of posttraumatic stress disorder in people with serious mental illness within forensic and rehabilitation servicesPosttraumatic stress disorderMental Health - SchizophreniaMental Health - Other mental health disorders
ACTRN12618000683235niversity of Otago46